The PennZone

PHILADELPHIA, Aug. 13, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" or the "Company") on behalf of investors who purchased or otherwise acquired common shares of Spectrum between March 17, 2022 through September 22, 2022 (the "Class Period").

Investor Deadline: Investors who purchased or acquired Spectrum securities during the Class Period may, no later than September 24, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE.

More on The PennZone

• Modernizing Pole Data Collection for Next-Gen Network Expansion
• Assent Joins AWS ISV Accelerate Program
• TransCelerate and FDA Collaborate to Advance Use of Pragmatic Elements in Clinical Trials
• FreeTo.Chat Launches Silent Confessions, the Best Confession Site for Anonymous, Ad-Free Truth Sharing
• The Journey of a Soulful R&B Artist JNash

Spectrum is a biopharmaceutical company focused on oncology treatments.

The class action lawsuit alleges that Spectrum made false or misleading statements to investors regarding its Pinnacle Study, a clinical trial involving poziotinib, a drug intended to treat certain lung cancer patients.

Spectrum shares were delisted following the Company's merger with Assertio Holdings, Inc. (NASDAQ: ASRT).

If you are a Spectrum investor and would like to learn more about this action, CLICK HERE or please contact Berger Montague: Andrew Abramowitz at [email protected] or (215) 875-3015, or Caitlin Adorni at [email protected] or (267)764-4865.

More on The PennZone

• Dr. Sanju P. Jose Highlights Expertise in Periodontics and Implant Dentistry
• Contracting Resources Group Appears Again on the Inc. List of Fastest-Growing Companies
• Chuckie F. Mahoney Memorial Foundation Awards 2025-26 School Grants
• Phinge®, Home of Netverse® and Netaverse™ With Verified and Safer AI Announces "Test the Waters" Campaign for Potential Regulation A+ Offering
• Sustainably Made in New York: MOO Vodka and Cayuga Clear Expand Statewide Distribution

About Berger Montague
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.

For more information or to discuss your rights, please contact:
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]

Caitlin Adorni
Berger Montague
(267) 764-4865
[email protected]

SOURCE Berger Montague

---

Show All News | Report Violation